###### Key questions

What is already known about this subject?
=========================================

-   Smokeless tobacco use is known to pose numerous health risks, but reviews and analyses of circulatory disease risks in high-income countries may be outdated or incomplete.

What does this study add?
=========================

-   This study finds that US smokeless tobacco users have increased risks of heart disease and stroke compared with non-users, although it did not observe increased risk among Swedish smokeless users.

How might this impact on clinical practice?
===========================================

-   Practitioners should advise their patients who use smokeless tobacco products of the known health risks and provide advice on cessation.

Introduction {#s1}
============

The health effects of smokeless tobacco use are of considerable research and public health interest. Globally, more than 300 million people use these products, many of them in low-income countries.[@R1] In the USA, it has been estimated that smokeless tobacco use was responsible for approximately 1600 new cases of oral cancer, 500 new cases of pancreatic cancer and 200 new cases of oesophageal cancer in 2008.[@R1] Although some types of smokeless tobacco have been found to be associated with circulatory conditions including heart disease and stroke,[@R2] comprehensive reviews of this association in high-income countries may be out of date or limited by the number of study estimates they identified. Moreover, disease burden calculations for smokeless tobacco in the USA are generally unavailable for these conditions.

Several reviews of smokeless tobacco use and circulatory disease risk have been conducted previously. Lee[@R2] reviewed 11 studies from Sweden and the USA in 2007 and found an association between smokeless tobacco use and increased heart disease risk based on eight studies, increased stroke risk based on five studies and increased overall circulatory disease risk based on three studies. Boffetta and Straif[@R3] also identified 11 observational studies from Sweden and the USA in 2009 and found an association between smokeless tobacco use and increased risk of fatal myocardial infarction based on eight studies and increased risk of fatal stroke based on five studies. Zhang *et al* [@R4] identified eight studies from Asian countries, principally Bangladesh, India and Taiwan in 2010. They found increased cardiovascular and ischaemic heart disease risk based on six studies and increased cerebrovascular risk based on three studies for ever users of chewing substances with and without tobacco. Siddiqi *et al* [@R5] reviewed 13 studies of heart disease and stroke risk from South Asia and Sweden in 2015 and did not observe increased risk in Swedish studies. They noted that the multicountry INTERHEART study with data from 52 countries found increased heart disease risk among smokeless tobacco users. Vidyasagaran *et al* [@R6] reviewed 20 studies from South Asia, Sweden and the USA in 2016 and found increased mortality risk from ischaemic heart disease and stroke among ever smokeless tobacco users. Results varied by region, with a significant association for non-fatal ischaemic heart disease in Asian but not European studies. Sinha *et al* [@R7] identified 16 studies of all-cause and cause-specific mortality risk from South Asia, Sweden and the USA in 2018. They found smokeless tobacco use to be associated with increased mortality risk for all causes as well as ischaemic heart disease and stroke. Gupta *et al* [@R8] reviewed 20 studies from South Asia, Iran, Sweden and the USA, also in 2018, and found an association between smokeless tobacco use and fatal coronary heart disease in Swedish studies and studies overall.

Several reviews of smokeless tobacco use and circulatory disease risks have thus been published, but these reviews have varied in terms of the geographical areas and smokeless tobacco products they covered, the studies they included and the findings they reported. In addition, new studies on this topic have been published.[@R9] The aim of this study therefore is to produce an updated systematic review and meta-analysis of smokeless tobacco use and circulatory disease risks, specifically focusing on studies conducted among European and North American smokeless tobacco users. These regions were selected because products from these areas, such as chewing tobacco, moist snuff and snus, are commonly sold in the US market and thus regulated by the US Food and Drug Administration. Moreover, smokeless tobacco products from other areas such as South Asia and Africa can be quite different in terms of product characteristics and health risks from products sold in the USA.[@R12] This review covers circulatory conditions including heart disease, stroke and other circulatory conditions.

Methods {#s2}
=======

The study consisted of a systematic review and meta-analysis of studies of smokeless tobacco use and circulatory disease risk in Europe and North America that contained a quantitative relative risk estimate for users compared with non-users. The review and meta-analysis were conducted in accordance with PRISMA[@R13] (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines using a prespecified study protocol. Given that the study did not involve primary data collection or analysis, the study was considered exempt from human subjects committee review. In August 2017, we searched PubMed, EMBASE, Web of Science and Ebscohost databases for references that contained terms for both smokeless tobacco and circulatory conditions. The online [supplementary appendix](#SP1){ref-type="supplementary-material"} shows the relevant search terms for each database. Two reviewers (GMA and JTC) independently reviewed the titles and abstracts of these articles and identified relevant references for further review. Each reviewer then evaluated each reference for inclusion in the study. We searched for relevant unpublished studies by reviewing previous reviews and the reference lists of selected articles. Preliminary studies by two groups of researchers[@R14] were identified in our search but were not included in the review because they have yet to be published. The rationale for their exclusion is explained in greater detail in the Discussion section. The reviewers then extracted relevant information from identified studies including study design, country, study size, smokeless tobacco type, and circulatory conditions or mortality outcomes. Because studies often report more than one estimate, specific estimates for each outcome from each study were extracted using the following order of preference lists: smokeless tobacco type (all, snuff or snus, chewing tobacco), smokeless tobacco use status (current or former, ever), cigarette smoking status (never, non-current, any smoking status), medical outcome (specific circulatory conditions such as heart disease or stroke, all circulatory conditions), outcome type (all cases, then fatal or non-fatal events for the type that has the greater number of cases) and adjustment for other risk factors (the most extensive adjustment available). Medical outcomes were categorised as ischaemic heart disease (conditions included in International Classification of Diseases (ICD)-9 410--414, sometimes characterised as myocardial infarction, coronary heart disease or cardiovascular disease in specific studies), stroke (ICD-9 430--438) and other circulatory conditions (the remainder of ICD-9 390--459). The quality of these studies was also assessed using the Newcastle-Ottawa scale, a standardised scale to assess the quality of non-randomised studies included in systematic reviews and meta-analyses.[@R17] Studies were assigned a maximum of nine stars based on established criteria for the selection of study groups, the comparability of groups and the ascertainment of exposure for case--control studies and outcome for cohort studies. Additional information about the scale and its criteria are provided in online [supplementary tables](#SP2){ref-type="supplementary-material"}.
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These estimates were then combined using meta-analysis with a random-effects model to produce summary relative risk estimates by country and outcome. Heterogeneity was assessed through χ^2^ tests of Cochran's Q as well as the I^2^ statistic. Publication bias was assessed through funnel plots, although the number of studies by country and outcome was limited. Two pooled analyses have been published that combine individual-level data from eight Swedish cohort studies, some of which had previously produced relative risk estimates for heart disease and stroke.[@R18] Estimates from the pooled analyses were included in the meta-analyses, and estimates from studies that were included in the pooled analyses were not, but the published studies are described in the summary tables. We also conducted sensitivity analyses omitting the small number of estimates from case--control and cross-sectional studies. Differences in study estimates between countries for outcomes were assessed using random-effects meta-regression, although again the number of studies and study events limited the ability to detect statistically significant differences. Meta-analysis was conducted using Stata version 15.

Results {#s3}
=======

A total of 816 unique references were found through searching electronic databases, and reviewers identified 32 of these references for further review. [Figure 1](#F1){ref-type="fig"} shows that five references were excluded as previous reviews,[@R2] two references were excluded as abstracts of conference presentations[@R14] and one reference did not present country-specific relative risk estimates for smokeless tobacco use.[@R21]

![Flow diagram for selection of studies for review.](openhrt-2018-000846f01){#F1}

[Table 1](#T1){ref-type="table"} summarises the characteristics of 17 identified cohort studies that produced relevant risks estimates for smokeless tobacco use, 11 of which were conducted in Sweden[@R22]and six in the USA.[@R9]Results from the Construction Worker's study, Malmo study, Twin Registry study and MONICA study[@R22] were included in two pooled analyses of data on acute myocardial infarction and stroke from eight cohort studies in Sweden.[@R18] [Table 2](#T2){ref-type="table"} presents the characteristics of five case--control studies from Sweden[@R36] and one analysis of cross-sectional survey data from the USA.[@R11] Four of the Swedish case--control studies[@R36] were drawn from the MONICA cohort study, which was also included in the pooled analyses. Study quality was generally good, with 12 of the 17 cohort studies, both of the pooled analyses, and three of the five case--control studies receiving at least seven stars on the Newcastle-Ottawa scale. Online [supplementary table 1 and 2](#SP2){ref-type="supplementary-material"} provides detailed scores by study for each of the scale's criteria. Studies scored well on ascertainment of exposure, selection of controls or non-exposed cohort members, use of control variables for other risk factors and assessment of outcome. Most cohort studies did not provide adequate information about follow-up for study participants according to the scale's criteria, and a majority of case--control studies did not provide sufficient response rate information. [Table 3](#T3){ref-type="table"} shows the relevant estimates that were extracted from each study as well as the other factors that were adjusted for in the analyses.

###### 

Cohort studies and pooled analyses of smokeless tobacco use and circulatory risks

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                       Country   Study population                                                                                                                                                                              Study period                                                                                                                                                Sex       Age at baseline                                  Study size                                        Smokeless tobacco type                         Outcomes                                                                                          ICD codes                                                                                                                                                                      Newcastle-Ottawa score
  --------------------------- --------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------- --------- ------------------------------------------------ ------------------------------------------------- ---------------------------------------------- ------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------
  Bolinder *et al* [@R22]\    Sweden    Construction workers receiving medical check-ups from the Organisation for Working Environment Safety and Health                                                                              Baseline visit in 1971--1974 with mortality follow-up from 1974 to 1985                                                                                     M         ≤65 years                                        84 781\                                           Snus                                           Mortality from IHD, stroke and CID                                                                IHD (ICD-8 410--414); stroke (ICD-8 430--438); all CID (ICD-8 390--458)                                                                                                        6
  1994                                                                                                                                                                                                                                                                                                                                                                                                                                                       6927 smokeless users                                                                                                                                                                                                                                                                                                                                                              

  Accortt *et al* [@R33]\     USA       NHANES I Epidemiologic Follow-up Survey (NHEFS) participants                                                                                                                                  NHANES I was conducted from 1971 to 1975 and NHEFS follow-up occurred in 1982--1984, 1986, 1987 and 1992                                                    M, F      45--75 years                                     12 172\                                           Smokeless tobacco                              Mortality from IHD, stroke and all CID                                                            IHD (ICD-9 codes 410--414); stroke (ICD-9 codes 430--438); all CID (ICD-9 codes 390--459)                                                                                      9
  2002                                                                                                                                                                                                                                                                                                                                                                                                                                                       505 exclusive smokeless tobacco users                                                                                                                                                                                                                                                                                                                                             

  Henley *et al* [@R34]﻿﻿﻿\   USA       Participants in American Cancer Society\'s Cancer Prevention Study (CPS) I                                                                                                                    Baseline survey in 1959 with mortality follow-up through 1972                                                                                               M         ≥30 years                                        77 407\                                           Smokeless tobacco, snuff, chewing tobacco      Mortality from coronary heart disease, stroke, other CID and all CID                              Coronary heart disease (ICD-7 420); stroke (330-334); other CID (ICD-7 335--398, 400--419, 421--468); all CID (ICD-7 330--468)                                                 8
  2005                                                                                                                                                                                                                                                                                                                                                                                                                                                       7745 current smokeless tobacco users                                                                                                                                                                                                                                                                                                                                              

  Henley *et al* [@R34]﻿\     USA       Participants in CPS II                                                                                                                                                                        Baseline survey in 1982 with mortality follow-up through 2000                                                                                               M         ≥30 years                                        114 809\                                          Smokeless tobacco, snuff, chewing tobacco      Mortality from coronary heart disease, stroke, other CID and all CID                              Coronary heart disease (ICD-9 410--414); stroke (ICD-9 430--438); other CID (ICD-9 390--405, 415--429, 450--459); all CID (ICD-9 390--459)                                     8
  2005                                                                                                                                                                                                                                                                                                                                                                                                                                                       2488 current smokeless tobacco users                                                                                                                                                                                                                                                                                                                                              

  Johansson *et al* [@R23]\   Sweden    Participants in the Swedish Annual Level-of-Living Survey (SALLS)                                                                                                                             Baseline survey in 1988--1989 with follow-up through 2000                                                                                                   M         30--74 years                                     3120\                                             Snus                                           Incidence and mortality from coronary heart disease                                               Coronary heart disease (ICD-9 410--414 and ICD-10 I20--I25)                                                                                                                    8
  2005                                                                                                                                                                                                                                                                                                                                                                                                                                                       107 never smoking daily smokeless tobacco users                                                                                                                                                                                                                                                                                                                                   

  Haglund *et al* [@R24]﻿\    Sweden    Participants in the Swedish Survey of Living Conditions (ULF)                                                                                                                                 Baseline survey in 1988--1989 with follow-up through 2003                                                                                                   M         16--74 years                                     5002\                                             Snus                                           Incidence and mortality from IHD and stroke                                                       IHD (ICD-9 410--414 and ICD-10 I20--I25); stroke (ICD-9 430--438 and ICD-10 I60--I69)                                                                                          7
  2007                                                                                                                                                                                                                                                                                                                                                                                                                                                       885 smokeless tobacco users                                                                                                                                                                                                                                                                                                                                                       

  Henley *et al[@R35]*\       USA       Former smokers participating in CPS II                                                                                                                                                        Baseline survey in 1982 with mortality follow-up through 2002                                                                                               M         ≥30 years                                        116 395\                                          Smokeless tobacco, chewing tobacco and snuff   Mortality from coronary heart disease and stroke                                                  Coronary heart disease (ICD-9 410--414) and stroke (ICD-9 430--438)                                                                                                            6
  2007                                                                                                                                                                                                                                                                                                                                                                                                                                                       4443 smokeless tobacco users                                                                                                                                                                                                                                                                                                                                                      

  Hergens *et al* [@R25]\     Sweden    Construction workers receiving medical check-ups from the Organisation for Working Enviroment Safety and Health                                                                               Baseline was first visit after 1978 to 1993 with follow-up through 2004                                                                                     M         35--65 years (for analysis)                      118 395\                                          Snus                                           Incidence and mortality from acute myocardial infarction                                          Acute myocardial infarction (ICD-9 410 and ICD-10 I21--I22)                                                                                                                    7
  2007                                                                                                                                                                                                                                                                                                                                                                                                                                                       \~32 360 current smokeless tobacco users                                                                                                                                                                                                                                                                                                                                          

  Hergens *et al* [@R26]\     Sweden    Construction workers receiving medical check-ups from the Organisation for Working Enviroment Safety and Health                                                                               Baseline was first visit after 1978 to 1993 with follow-up through 2003                                                                                     M         \<35--55+ years                                  118 465\                                          Snus                                           Incidence and mortality from stroke                                                               Stroke (ICD-7 through ICD-10)                                                                                                                                                  7
  2008                                                                                                                                                                                                                                                                                                                                                                                                                                                       27% current smokeless tobacco users                                                                                                                                                                                                                                                                                                                                               

  Hergens *et al* [@R32]\     Sweden    Construction workers receiving medical check-ups from the Organisation for Working Enviroment Safety and Health                                                                               Baseline was first visit after 1978 to 1993                                                                                                                 M         \<45--65+ years                                  120 930\                                          Snus                                           Incidence of hypertension                                                                         Hypertension (ICD-7 440--447, ICD-8 400--404, ICD-9 401--405 and ICD-10 I10--I15)                                                                                              6
  2008                                                                                                                                                                                                                                                                                                                                                                                                                                                       32 973 current smokeless tobacco users                                                                                                                                                                                                                                                                                                                                            

  Roosaar *et al* [@R27]\     Sweden    Participants from two municipalities in Uppsala County, Sweden                                                                                                                                Baseline interview was in 1973--1974 with follow-up through 2002                                                                                            M         ≥14 years                                        9976\                                             Snus                                           Mortality from CID                                                                                All CID (ICD-8 390--458, ICD-9 390--458 and ICD-10 I00--I99)                                                                                                                   7
  2008                                                                                                                                                                                                                                                                                                                                                                                                                                                       1548 ever daily smokeless tobacco users                                                                                                                                                                                                                                                                                                                                           

  Hansson *et al* [@R28]\     Sweden    Participants from the Swedish Twin Registry who took part in the Screening Across the Lifespan Twin Study (SALT)                                                                              Telephone interview conducted in 1998--2002 with follow-up through 2005                                                                                     M         ≥40 years                                        16 642\                                           Snus                                           Incidence and mortality from acute myocardial infarction, coronary revascularisation and stroke   Acute myocardial infarction and coronary revascularisation (ICD-10 I20--I21, I24--I25 excluding I25.2) and stroke (ICD-9 430--431, 433--436; ICD-10 I60--I61, I63--I64, G45)   7
  2009                                                                                                                                                                                                                                                                                                                                                                                                                                                       2661 current smokeless tobacco users                                                                                                                                                                                                                                                                                                                                              

  Janzon *et al* [@R29]\      Sweden    Participants in the Malmo Cancer and Diet Study (MCDS)                                                                                                                                        Baseline examination from 1991 to 1996 with follow-up through 2004                                                                                          M         45--73 years                                     10 473\                                           Snus                                           Incidence of acute myocardial infarction and stroke or mortality from IHD                         Acute myocardial infarction (ICD-9 410), IHD (ICD-9 410--414) and stroke (ICD-9 430, 431, 434 and 436)                                                                         8
  2009                                                                                                                                                                                                                                                                                                                                                                                                                                                       737 smokeless tobacco users                                                                                                                                                                                                                                                                                                                                                       

  Yatsuya *et al* [@R10]\     USA       Participants in the Atherosclerosis Risk in Communities study                                                                                                                                 Recruitment in 1987--1989 with follow-up through 2005                                                                                                       M         45--64 years                                     14 498\                                           Smokeless tobacco                              Incidence or mortality from coronary heart disease and incidence of stroke                        Not provided                                                                                                                                                                   8
  2010                                                                                                                                                                                                                                                                                                                                                                                                                                                       456 current smokeless tobacco users                                                                                                                                                                                                                                                                                                                                               

  Arefalk *et al* [@R30]\     Sweden    Participants in the Uppsala Longitudinal Study of Adult Men (ULSAM); participants in the Construction Worker's Cohort (CWC)                                                                   ULSAM---baseline survey in 1970--1973 with follow-up from 1991 to 1995 through 2002; CWC---baseline check-up was from 1978 on with follow-up through 2003   M         ULSAM---50 years; CWC---mean age of 31.5 years   ULSAM---1076\                                     Snus                                           ULSAM and CWC---incidence of heart failure                                                        CWC---heart failure (ICD-7 434.1, 434.2, 440.99 and 441.99; ICD-8 427.00, 427.10 and 428.99; ICD-9 428; ICD-10 I50, I11.0)                                                     6
  2012                                                                                                                                                                                                                                                                                                                                                                                                                                                       78 smokeless tobacco users;\                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                             CWC---118 425\                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                             32 281 current smokeless tobacco users                                                                                                                                                                                                                                                                                                                                            

  Arefalk *et al* [@R31]\     Sweden    Participants in SWEDEHEART database registries                                                                                                                                                Snus users who were admitted to a coronary care unit with myocardial infarction from 2005 to 2009 were identified from patient databases                    M and F   Mean 61.9 years                                  675 snus quitters\                                Snus                                           Incidence or mortality from repeat myocardial infarction, stroke and heart failure                Acute myocardial infarction (ICD-10 I21--I23), stroke (ICD-10 I60--I64) and heart failure (ICD-10 I50)                                                                         5
  2014                                                                                                                                                                                                                                                                                                                                                                                                                                                       1799 snus users after myocardial infarction                                                                                                                                                                                                                                                                                                                                       

  Timberlake *et al* [@R9]\   USA       Participants in the National Longitudinal Mortality Study                                                                                                                                     Participants completed the Tobacco Use Supplement to the Current Population Survey (TUS-CPS) from 1985 to 2011 with follow-up through 2011                  M         Not stated                                       349 282\                                          Smokeless tobacco, snuff and chewing tobacco   Mortality from coronary heart disease and stroke                                                  Coronary heart disease and stroke as categorised in standardised list of causes of death based on ICD-9 and ICD-10                                                             7
  2017                                                                                                                                                                                                                                                                                                                                                                                                                                                       4919 current smokeless tobacco users                                                                                                                                                                                                                                                                                                                                              

  Pooled analyses                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Hansson *et al* [@R18]\     Sweden    Participants from eight cohort studies---CWC, MCDS, MONICA, National March Cohort, SALT, Stockholm Public Health Cohort, Scania Public Health Cohort, and Work, Lipids and Fibrinogen Study   Recruitment ranged from 1978 to 2004                                                                                                                        M         mean age of recruitment was 35 years             130 361\                                          Snus                                           Incidence and mortality from acute myocardial infarction                                          Acute myocardial infarction (ICD-7 410.10 and 420.17; ICD-8 410; ICD-9 410; ICD-10 I21)                                                                                        8
  2012                                                                                                                                                                                                                                                                                                                                                                                                                                                       25% current smokeless tobacco users                                                                                                                                                                                                                                                                                                                                               

  Hansson *et al* [@R19]\     Sweden    Participants from eight cohort studies---CWC, MCDS, MONICA, National March Cohort, SALT, Stockholm Public Health Cohort, Scania Public Health Cohort, and Work, Lipids and Fibrinogen Study   Recruitment ranged from 1978 to 2004                                                                                                                        M         Mean age of recruitment was 35 years             130 485\                                          Snus                                           Incidence and mortality from stroke                                                               Stroke (ICD-9 430--431, 434 and 436; ICD-10 I60--I61, I63 and I64; and corresponding codes for ICD-7 and ICD-8)                                                                8
  2014                                                                                                                                                                                                                                                                                                                                                                                                                                                       32 542 current smokeless tobacco users                                                                                                                                                                                                                                                                                                                                            
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CID, circulatory disease;IHD, ischaemic heart disease; MONICA, Multinational Monitoring of Trends and Determinants in Cardiovascular Health; NHANES, National Health and Nutrition Examination Survey.

###### 

Case--control and cross-sectional studies of smokeless tobacco use and circulatory risks

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                        Country   Study population                                                                                                                                                  Study period                                          Sex       Age                                                       Sample size                         Smokeless tobacco type   Conditions                                                                      Newcastle-Ottawa score
  ---------------------------- --------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------- --------- --------------------------------------------------------- ----------------------------------- ------------------------ ------------------------------------------------------------------------------- ------------------------
  Huhtasaari *et al* [@R36]\   Sweden    Cases and controls were participants in the MONICA study                                                                                                          1989--1991                                            M         35--64 years                                              585 cases\                          Snus                     Acute myocardial infarction                                                     8
  1992                                                                                                                                                                                                                                                                                                                               589 controls                                                                                                                                 

  Huhtasaari *et al* [@R37]\   Sweden    Cases and controls were participants in the MONICA study matched on age and county                                                                                1991--1993                                            M         25--64 years                                              687 cases\                          Snus                     Acute myocardial infarction                                                     7
  1999                                                                                                                                                                                                                                                                                                                               687 controls                                                                                                                                 

  Asplund *et al* [@R38]\      Sweden    Cases and controls were participants in the MONICA study or Vasterbotten Intervention Project (VIP) matched on sex, age, area, examination date and cohort        1985--2000                                            M         25--74 years                                              276 cases\                          Snus                     Stroke                                                                          6
  2003                                                                                                                                                                                                                                                                                                                               551 controls                                                                                                                                 

  Hergens *et al* [@R40]\      Sweden    Cases and controls were participants in the Stockholm Heart Epidemiology Project and Vasternorrland Heart Epidemiology Project matched on age and hospital area   Stockholm---1992--1993, Vasternorrland---1993--1994   M         Stockholm---45--70 years, Vasternorrland---45--65 years   1432 cases\                         Snus                     Acute myocardial infarction                                                     8
  2005                                                                                                                                                                                                                                                                                                                               1810 controls                                                                                                                                

  Wennberg *et al* [@R39]\     Sweden    Cases and controls were participants in the MONICA and VIP studies matched on sex, age, survey date and area                                                      1985--1999                                            M and F   30+ years                                                 525 cases\                          Snus                     Acute myocardial infarction or sudden cardiac death                             6
  2007                                                                                                                                                                                                                                                                                                                               1798 controls                                                                                                                                

  Cross-sectional study                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Mushtaq *et al* [@R11]\      USA       Participants from Oklahoma in the Behavioral Risk Factor Surveillance System                                                                                      1999--2001                                            M and F   18+ years                                                 10 332 participants\                Smokeless tobacco        Angina, coronary heart disease, heart attack, myocardial infarction or stroke   NA
  2010                                                                                                                                                                                                                                                                                                                               1796 ever smokeless tobacco users                                                                                                            
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

MONICA, Multinational Monitoring of Trends and Determinants in Cardiovascular Health; NA, not applicable.

###### 

Selected estimates of circulatory risk for smokeless tobacco users

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Number   Study                        Country   Sex       Smokeless tobacco Status   Cigarette smoking status   Condition               Measure   Estimates (95% CI)    Adjustment factors
  -------- ---------------------------- --------- --------- -------------------------- -------------------------- ----------------------- --------- --------------------- ------------------------------------------------------------------------------------------------------------------------
  1        Huhtasaari *et al* [@R37]\   Sweden    M         Former                     Never                      IHD                     OR        1.23 (0.54 to 2.82)   Age, area
           1999                                                                                                                                                           

  2        Accortt *et al* [@R33]\      USA       M         Ever                       Never                      IHD                     HR        0.6 (0.3 to 1.2)      Age, race, income, alcohol, exercise, diet, blood pressure, cholesterol, BMI
           2002                                                                                                                                                           

  3        Accortt *et al* [@R33]\      USA       F         Ever                       Never                      IHD                     HR        1.4 (0.8 to 2.2)      Age, race, income, alcohol, exercise, diet, blood pressure, cholesterol, BMI
           2002                                                                                                                                                           

  4        Accortt *et al* [@R33]\      USA       M         Ever                       Never                      Stroke                  HR        0.7 (0.2 to 2.0)      Age, race, income, alcohol, exercise, diet, blood pressure, cholesterol, BMI
           2002                                                                                                                                                           

  5        Accortt *et al* [@R33]\      USA       F         Ever                       Never                      Stroke                  HR        1.0 (0.3 to 2.9)      Age, race, income, alcohol, exercise, diet, blood pressure, cholesterol, BMI
           2002                                                                                                                                                           

  6        Henley *et al* [@R34]\       USA       M         Current                    Never                      IHD                     HR        1.12 (1.03 to 1.21)   Age, race, education, BMI, exercise, alcohol, employment, diet, aspirin
           2005 (CPS I)                                                                                                                                                   

  7        Henley *et al* [@R34]\       USA       M         Current                    Never                      Stroke                  HR        1.46 (1.31 to 1.64)   Age, race, education, BMI, exercise, alcohol, employment, diet, aspirin
           2005 (CPS I)                                                                                                                                                   

  8        Henley *et al* [@R34]\       USA       M         Current                    Never                      Other CID               HR        1.05 (0.91 to 1.22)   Age, race, education, BMI, exercise, alcohol, employment, diet, aspirin
           2005 (CPS I)                                                                                                                                                   

  9        Henley *et al* [@R34]\       USA       M         Current                    Never                      IHD                     HR        1.26 (1.08 to 1.47)   Age, race, education, BMI, exercise, alcohol, employment, diet, aspirin
           2005 (CPS II)                                                                                                                                                  

  10       Henley *et al* [@R34]\       USA       M         Current                    Never                      Stroke                  HR        1.40 (1.10 to 1.79)   Age, race, education, BMI, exercise, alcohol, employment, diet, aspirin
           2005 (CPS II)                                                                                                                                                  

  11       Henley *et al* [@R34]\       USA       M         Current                    Never                      Other CID               HR        1.07 (0.82 to 1.39)   Age, race, education, BMI, exercise, alcohol, employment, diet, aspirin
           2005 (CPS II)                                                                                                                                                  

  12       Henley *et al* [@R34]\       USA       M         Former                     Never                      IHD                     HR        0.70 (0.52 to 0.95)   Age, race, education, BMI, exercise, alcohol, employment, diet, aspirin
           2005 (CPS II)                                                                                                                                                  

  13       Henley *et al* [@R34]\       USA       M         Former                     Never                      Stroke                  HR        1.21 (0.83 to 1.76)   Age, race, education, BMI, exercise, alcohol, employment, diet, aspirin
           2005 (CPS II)                                                                                                                                                  

  14       Henley *et al* [@R34]\       USA       M         Former                     Never                      Other CID               HR        1.20 (0.83 to 1.72)   Age, race, education, BMI, exercise, alcohol, employment, diet, aspirin
           2005 (CPS II)                                                                                                                                                  

  15       Hergens *et al* [@R40]\      Sweden    M         Current                    Never                      IHD                     OR        0.73 (0.35 to 1.50)   Age, hospital area
           2005                                                                                                                                                           

  16       Hergens *et al* [@R40]\      Sweden    M         Former                     Never                      IHD                     OR        1.20 (0.46 to 3.10)   Age, hospital area
           2005                                                                                                                                                           

  17       Johansson *et al* [@R23]\    Sweden    M         Current                    Never                      IHD                     HR        1.41 (0.61 to 3.28)   Age, physical activity, BMI, diabetes, hypertension
           2005                                                                                                                                                           

  18       Haglund *et al* [@R24]\      Sweden    M         Current                    Non-current                IHD                     IRR       0.77 (0.51 to 1.15)   Age, area, socioeconomic status, exercise, health
           2007                                                                                                                                                           

  19       Haglund *et al﻿* [@R24]\     Sweden    M         Current                    Non-current                Stroke                  IRR       1.07 (0.65 to 1.77)   Age, area, socioeconomic status, exercise, health
           2007                                                                                                                                                           

  20       Henley *et al[@R35]*\        USA       M         Current                    Former                     IHD                     HR        1.13 (1.00 to 1.29)   Age, race, education, previous smoking, BMI, exercise, alcohol, employment, diet, aspirin
           2007                                                                                                                                                           

  21       Henley *et al[@R35]*\        USA       M         Current                    Former                     Stroke                  HR        1.24 (1.01 to 1.53)   age, race, education, previous smoking, BMI, exercise, alcohol, employment, diet, aspirin
           2007                                                                                                                                                           

  22       Hergens *et al* [@R25]\      Sweden    M         Former                     Never                      IHD                     HR        0.76 (0.55 to 1.05)   Age, BMI, region of residence
           2007                                                                                                                                                           

  23       Wennberg *et al* [@R39]\     Sweden    M         Former                     Never                      IHD                     OR        0.66 (0.32 to 1.34)   Age, sex, BMI, physical activity, education, cholesterol
           2007                                                                                                                                                           

  24       Hergens *et al* [@R26]\      Sweden    M         Former                     Never                      Stroke                  HR        0.72 (0.50 to 1.02)   age, BMI, region of residence
           2008                                                                                                                                                           

  25       Hergens *et al* [@R32]\      Sweden    M         Current                    Never                      Hypertension            HR        1.43 (1.12 to 1.83)   Age, BMI, region of residence
           2008                                                                                                                                                           

  26       Hergens *et al* [@R32]\      Sweden    M         Former                     Never                      Hypertension            HR        0.85 (0.40 to 1.79)   Age, BMI, region of residence
           2008                                                                                                                                                           

  27       Roosaar *et al* [@R27]\      Sweden    M         Ever                       Never (daily)              IHD                     HR        1.15 (0.97 to 1.37)   Age, period, area, alcohol consumption, age×period, age×smoking, age×area
           2008                                                                                                                                                           

  28       Hansson *et al* [@R28]\      Sweden    M         Former                     Never                      IHD                     HR        1.07 (0.56 to 2.03)   Age, diabetes, high blood pressure, high cholesterol
           2009                                                                                                                                                           

  29       Hansson *et al* [@R28]\      Sweden    M         Former                     Never                      Stroke                  HR        1.35 (0.65 to 2.82)   Age, diabetes, high blood pressure, high cholesterol
           2009                                                                                                                                                           

  30       Mushtaq *et al* [@R11]\      USA       M and F   Current                    Never                      IHD and stroke          OR        1.14 (0.55 to 2.39)   Age, race, sex, BMI
           2010                                                                                                                                                           

  31       Mushtaq *et al* [@R11]\      USA       M and F   Former                     Never                      IHD and stroke          OR        1.25 (0.77 to 2.03)   Age, race, sex, BMI
           2010                                                                                                                                                           

  32       Yatsuya *et al* [@R10]\      USA       M         Current                    Non-current                IHD and stroke          HR        1.31 (1.06 to 1.61)   Age, sex, race, education, income, alcohol, exercise, cigarette smoking, cigar and pipe use, secondhand smoke exposure
           2010                                                                                                                                                           

  33       Yatsuya *et al* [@R10]\      USA       M         Former                     Non-current                IHD and stroke          HR        0.90 (0.73 to 1.11)   Age, sex, race, education, income, alcohol, exercise, cigarette smoking, cigar and pipe use, secondhand smoke exposure
           2010                                                                                                                                                           

  34       Arefalk *et al* [@R30]\      Sweden    M         Current                    Any\*                      Heart failure           HR        2.09 (1.00 to 4.39)   Age, smoking, BMI, alcohol, occupation, health conditions
           2012                                                                                                                                                           

  35       Arefalk *et al* [@R30]\      Sweden    M         Current                    Never                      Heart failure           HR        1.24 (0.97 to 1.59)   Age, BMI, region, prior heart attack, blood pressure
           2012                                                                                                                                                           

  36       Arefalk *et al* [@R30]\      Sweden    M         Former                     Never                      Heart failure           HR        0.99 (0.44 to 2.22)   Age, BMI, region, prior heart attack, blood pressure
           2012                                                                                                                                                           

  37       Hansson *et al* [@R18]\      Sweden    M         Current                    Never                      IHD                     HR        1.04 (0.93 to 1.17)   Age, BMI
           2012                                                                                                                                                           

  38       Arefalk *et al* [@R31]\      Sweden    M and F   Continuing                 Any                        Cardiovascular events   HR        0.38 (0.11 to 1.32)   Age, sex, smoking, health conditions, body measures, medications, occupation, exercise
           2014                                                                                                                                                           

  39       Hansson *et al* [@R19]\      Sweden    M         Current                    Never                      Stroke                  HR        1.04 (0.92 to 1.17)   Age, BMI
           2014                                                                                                                                                           

  40       Timberlake *et al* [@R9]\    USA       M         Current                    Never                      IHD                     HR        1.24 (1.05 to 1.46)   Age, sex, race/ethnicity, education, family income
           2017                                                                                                                                                           

  41       Timberlake *et al* [@R9]\    USA       M         Current                    Never                      Stroke                  HR        0.92 (0.67 to 1.27)   Age, sex, race/ethnicity, education, family income
           2017                                                                                                                                                           

  42       Timberlake *et al* [@R9]\    USA       M         Former                     Never                      IHD                     HR        0.93 (0.66 to 1.30)   Age, sex, race/ethnicity, education, family income
           2017                                                                                                                                                           

  43       Timberlake *et al* [@R9]\    USA       M         Former                     Never                      Stroke                  HR        1.33 (0.81 to 2.18)   Age, sex, race/ethnicity, education, family income
           2017                                                                                                                                                           
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Estimates for any cigarette smoking status were calculated for study participants without restriction by current or former smoking status.

BMI, body mass index; CID, circulatory disease; CPS, Cancer Prevention Study; IHD, ischaemic heart disease; IRR, incidence rate ratio.

[Table 4](#T4){ref-type="table"} and [figure 2](#F2){ref-type="fig"} present results from the meta-analyses. No increased risk of ischaemic heart disease or stroke was observed in Swedish studies among current or former snus users compared with non-users. An individual study found increased risk of hypertension among current snus users in Sweden.[@R32] In the USA, current smokeless tobacco users had increased risk of heart disease (relative risk (RR) 1.17, 95% CI 1.09 to 1.27) and stroke (RR 1.28, 95% CI 1.01 to 1.62). These results remained consistent with the inclusion of studies of ever smokeless tobacco users. Similar results were also generally observed in studies that looked at heart disease and stroke together. In the one study that looked at circulatory risks for former smokers who had switched to smokeless tobacco at the time of or after they quit exclusive cigarette smoking compared with former smokers who had quit tobacco use entirely, higher risks were found for switchers for heart disease (RR 1.13, 95% CI 1.00 to 1.29) and stroke (RR 1.24, 95% CI 1.01 to 1.53). In most cases, heterogeneity across study estimates within country was limited, although differences were observed for estimates of stroke risk for US smokeless tobacco users (I^2^=72.0%). Meta-analysis results from sensitivity analyses omitting estimates from case--control and cross-sectional studies were similar to results from the main analysis. Without estimates from case--control studies, the summary relative risk for ischaemic heart disease in Swedish studies was 1.05 (95% CI 0.93 to 1.17) for current smokeless tobacco users and 0.81 (95% CI 0.61 to 1.09) for former users compared with 1.04 (95% CI 0.93 to 1.16) for current users and 0.85 (95% CI 0.66 to 1.08) for former users in the main analysis. Meta-regression showed some evidence of differences between estimates by country, although the number of studies limited the ability to detect statistically significant differences. For example, for ischaemic heart disease the summary risk ratio of US to Swedish studies was 1.14 (95% CI 0.90 to 1.43), and the proportion of between-study variance explained by country (R^2^) was 29.6%.

![Meta-analysis of ischaemic heart disease risk estimates for current smokeless tobacco users in Sweden and the USA.](openhrt-2018-000846f02){#F2}

###### 

Meta-analyses of circulatory risks for smokeless tobacco users

  Country                                                                        Condition                 Smokeless tobacco status   Cigarette smoking status\*   Number of study estimates (estimate numbers†)   Relative risk (95% CI)   Measures of heterogeneity
  ------------------------------------------------------------------------------ ------------------------- -------------------------- ---------------------------- ----------------------------------------------- ------------------------ ---------------------------
  Sweden                                                                         Ischaemic heart disease   Current                    Never                        n=3 (15, 17, 37)                                1.04 (0.93 to 1.16)      p=0.494 I^2^=0.0%
  Current                                                                        Any                       n=4 (15, 17, 18, 37)       0.99 (0.85 to 1.16)          p=0.345 I^2^=9.7%                                                        
  Former                                                                         Never                     n=5 (1, 16, 22, 23, 28)    0.85 (0.66 to 1.08)          p=0.609 I^2^=0.0%                                                        
  Stroke                                                                         Current                   Never                      n=1 (39)                     1.04 (0.92 to 1.17)                             --                       
  Current                                                                        Any                       n=2 (19, 39)               1.04 (0.93 to 1.17)          p=0.914 I^2^=0.0%                                                        
  Former                                                                         Never                     n=2 (24, 29)               0.91 (0.50 to 1.64)          p=0.131 I^2^=56.2%                                                       
  Other circulatory disease                                                                                                                                                                                                                 
   Heart failure                                                                 Current                   Any                        n=2 (34, 35)                 1.43 (0.91 to 2.24)                             p=0.190 I^2^=41.9%       
  Former                                                                         Never                     n=1 (36)                   0.99 (0.44 to 2.22)          --                                                                       
   Hypertension                                                                  Current                   Never                      n=1 (25)                     1.43 (1.12 to 1.83)                             --                       
  Former                                                                         Never                     n=1 (26)                   0.85 (0.40 to 1.79)          --                                                                       
  All circulatory disease                                                        Ever                      Never                      n=1 (27)                     1.15 (0.97 to 1.37)                             --                       
  Among users with previous myocardial infarction ('quitters' vs 'continuers')                                                                                                                                                              
   Cardiovascular events                                                         Current                   Any                        n=1 (38)                     0.38 (0.11 to 1.32)                             --                       
  US                                                                             Ischaemic heart disease   Current                    Never                        n=3 (6, 9, 40)                                  1.17 (1.09 to 1.27)      p=0.292 I^2^=18.7%
  Current/ever                                                                   Never                     n=5 (2, 3, 6, 9, 40)       1.18 (1.06 to 1.31)          p=0.167 I^2^=38.2%                                                       
  Former                                                                         Never                     n=2 (12, 42)               0.80 (0.61 to 1.05)          p=0.220 I^2^=33.7%                                                       
  Stroke                                                                         Current                   Never                      n=3 (7, 10, 41)              1.28 (1.01 to 1.62)                             p=0.028 I^2^=72.0%       
  Current/ever                                                                   Never                     n=5 (4, 5, 7, 10, 41)      1.25 (1.00 to 1.55)          p=0.066 I^2^=54.6%                                                       
  Former                                                                         Never                     n=2 (13, 43)               1.25 (0.93 to 1.69)          p=0.766 I^2^=0.0%                                                        
  Other circulatory disease                                                                                                                                                                                                                 
   Circulatory disease excluding ischaemic heart disease and stroke              Current                   Never                      n=2 (8, 11)                  1.06 (0.93 to 1.20)                             p=0.902 I^2^=0.0%        
  All circulatory disease                                                                                                                                                                                                                   
   Ischaemic heart disease and stroke                                            Current                   Never                      n=1 (30)                     1.14 (0.55 to 2.39)                             --                       
  Former                                                                         Never                     n=1 (31)                   1.25 (0.77 to 2.03)          --                                                                       
   Ischaemic heart disease and stroke                                            Current                   Non-current (adjusted)     n=1 (32)                     1.31 (1.06 to 1.61)                             --                       
  Former                                                                         Non-current (adjusted)    n=1 (33)                   0.90 (0.73 to 1.11)          --                                                                       
  Among former cigarette smokers ('switchers')                                                                                                                                                                                              
   Ischaemic heart disease                                                       Current                   Former                     n=1 (20)                     1.13 (1.00 to 1.29)                             --                       
   Stroke                                                                        Current                   Former                     n=1 (21)                     1.24 (1.01 to 1.53)                             --                       

\*Meta-analyses of studies with any smoking status include all study estimates for that condition and smokeless tobacco use status regardless of cigarette smoking status in individual studies. Meta-analyses of studies with non-current smoking status include estimates from studies that excluded current but not former smokers.

†Study estimate numbers are from [table 3](#T3){ref-type="table"}.

Discussion {#s4}
==========

This study represents a systematic review and meta-analysis of studies of smokeless tobacco use and circulatory disease risk in Europe and North America. It has identified 17 cohort studies, five case--control studies, one cross-sectional analysis and two pooled data analyses with relevant risk estimates, all of which were conducted in Sweden or the USA. Meta-analysis results did not show increased risk of heart disease or stroke among smokeless tobacco users in Sweden compared with non-users, but did show increased heart disease and stroke risk for US smokeless tobacco users. These US results were consistent for current smokeless tobacco users compared with never tobacco users and for former smokers who had switched to smokeless tobacco use compared with former smokers who had quit tobacco use entirely.

Several previous meta-analyses have been conducted on this topic, but this study includes more recent studies and provides updated estimates. For example, Lee[@R2] reviewed studies of smokeless tobacco use and circulatory disease risk from Sweden and the USA in 2007 and Boffetta and Straif[@R3] conducted a similar review in 2009. Both analyses identified mortality follow-up studies published by Accortt *et al* [@R33] and Henley *et al* [@R34] as the only relevant US studies available at that time. Subsequent reviews on this topic have either identified only these studies[@R6] or no studies[@R5] from the USA. Our study has included estimates from several additional US studies that uise data from sources such as the prospective, community-based Atherosclerosis Risk in Communities Study,[@R10] the cross-sectional Behavioral Risk Factor Surveillance System survey of health behaviours and conditions,[@R11] and the nationally representative National Longitudinal Mortality Study (NLMS), which links Tobacco Use Supplement to the Current Population Survey data to mortality follow-up.[@R9]

The observed differences in results from meta-analyses for Sweden and the USA are generally consistent with the more limited results from previous reviews,[@R2] but the consistency of results across studies for multiple conditions in the two countries is striking. The observed increased circulatory disease risk among US smokeless tobacco users may be the result of various factors in terms of product characteristics and behavioural use. US smokeless tobacco products are known to contain varying levels of numerous constituents including nicotine, tobacco-specific nitrosamines (TSNAs) such as the carcinogens NNN and NNK, anions such as nitrite, nitrate and chloride, polycyclic aromatic hydrocarbons such as benzo\[*a*\]pyrene and volatile aldehydes such as formaldehyde.[@R41] They also vary in their concentrations of toxic metals such as arsenic, cadmium, chromium, nickel and lead.[@R42] Swedish snus products, in contrast, are subject to a quality control standard known as GothiaTek that sets maximum limits on product constituents including TSNAs, nitrite, benzo\[*a*\]pyrene and metals.[@R44] Studies have found that Swedish snus products generally have lower levels of various constituents including TSNAs such as NNN and NNK, anions such as nitrate and nitrite, and polycyclic aromatic hydrocarbons such as benzo\[*a*\]pyrene compared with US conventional smokeless tobacco products.[@R41] Specifically with regard to circulatory risks, Swedish snus has been found to have lower levels of the aldehyde acrolein than several commonly sold US traditional smokeless tobacco products,[@R41] and acrolein is known to have toxic effects after ingestion and to cause cardiovascular damage through various mechanisms including oxidative stress and endothelial dysfunction.[@R45] Swedish snus has also generally been found to have lower levels of toxic metals such as arsenic, cadmium and lead[@R46] that have been linked to cardiovascular disease,[@R47] although US moist snuff products have generally been found to meet the GothiaTek standard for most metals other than cadmium.[@R42]

The effect of nicotine on the circulatory system is complicated, but particularly relevant to the observed associations between smokeless tobacco use and circulatory disease risk. Studies have consistently found that cigarette smoking causes circulatory damage and disease through numerous pathways including oxidative injury, endothelial damage, enhanced thrombosis and chronic inflammation.[@R48] Even so, the American Heart Association has issued a policy statement that concluded that nicotine may contribute to the effects of smoking on cardiovascular health but that other constituents in cigarette smoke appear to have a much more important effect.[@R49] Research has found that nicotine, regardless of its route of administration, can increase blood pressure and heart rate.[@R48] A network meta-analysis of 21 randomised clinical trials involving nicotine replacement therapy (NRT) products found that NRT use was associated with increased risk of all cardiovascular events including less severe conditions such as heart palpitations (RR 2.29, 95% CI 1.39 to 3.82) but not necessarily with increased risk for severe cardiovascular events such as myocardial infarction, stroke or death (RR 1.95, 95% CI 0.26 4.30).[@R50] US smokeless tobacco users have been found to have nicotine exposure levels that may exceed those of cigarette smokers,[@R51] but nicotine absorption from cigarette smoke occurs much faster on average than from smokeless tobacco,[@R52] which may cause greater damage to the circulatory system.[@R49] Swedish snus products have been found to have total nicotine levels that may be lower than levels in US moist snuff products, even though free nicotine levels have been found to be comparable in US and Swedish products.[@R41]

As noted in the Methods section, we identified preliminary studies by two groups of researchers[@R14] that we did not include in our review because they have yet to be published. Nilsson *﻿et al* [@R14] examined acute myocardial infarction and snus use in a study of 726 Swedish cases and 726 controls. They did not find an association in this study population, which is consistent with results from our meta-analysis of snus use and ischaemic heart disease in Swedish studies. Fisher *﻿et al* from Altria Client Services[@R15] have presented relative risk estimates in conference presentations for US smokeless tobacco users from NLMS and National Health Interview Survey linked mortality data. They reported mortality HRs that were adjusted for self-reported health status, which may be viewed as an intermediate variable in the causal pathway between exposure and outcome. Estimates in their presentations from NLMS data are lower than comparable estimates reported by Timberlake *et al*, which are included in this review.

This study has certain limitations. Smokeless tobacco use was usually self-reported by study participants, and information on use was often limited to current or ever use. In studies with linkage to mortality data such as the Cancer Prevention Studies (CPS)[@R34] and NLMS,[@R9] smokeless tobacco use was only reported in the baseline survey, and many current users at baseline may have quit use during the follow-up period. It has been shown using CPS II data that smoking cessation can bias relative risk estimates downward over an extended follow-up period.[@R53] Study estimates also varied in the quantity and quality of adjustment for potential confounding risk factors, which may affect results. Some estimates by country and condition are based on a limited number of studies.

In conclusion, we have found that US smokeless tobacco users have increased risk of both heart disease and stroke, whereas we did not observe increased circulatory disease risk among Swedish smokeless tobacco users. Strengths of this analysis include the inclusion of additional, recent studies and estimates for former smokeless tobacco users and switchers from cigarettes to smokeless tobacco. Additional studies comparing constituent levels, use patterns and other characteristics of smokeless tobacco use across product types could help further strengthen our knowledge of the health risks of smokeless tobacco products.
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